[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain]. [electronic resource]
- Revista de neurologia Apr 2012
- 446-7; author reply 447-8 p. digital
Publication Type: Letter; Comment
1576-6578
Cost of Illness Cost-Benefit Analysis Humans Multiple Sclerosis, Relapsing-Remitting--drug therapy